Author

A. Ostrowska

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Pathology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 4 Approach:experimental assay· 4 Organism:human· 3 Organism:C. elegans· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Soto-Gutierrez· 3 shared R. M. Florentino· 3 shared T. Kurihara· 2 shared Y. Sun· 2 shared Z. Cetin· 2 shared Z. Hu· 2 shared Z. Liu· 2 shared A. R. Smith· 1 shared

Activity by Year

2019-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPathology

A. Soto-Gutierrez

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Increased motility in Campylobacter jejuni and changes in its virulence, fitness and morphology following protein expression on ribosomes with altered RsmA methylation

A. Sałamaszynska-Guz, M. Murawska, P. Bacal, A. Ostrowska, E. Kwiecien, I. Stefanska, S. Douthwaite

This paper investigates how altering RsmA methylation in Campylobacter jejuni affects its motility, virulence, and morphology through proteomic analysis of engineered strains.

bioRxiv · Jun 3, 2024 · PreprintMicrobiology

A rat model of cirrhosis with well-differentiated hepatocellular carcinoma induced by thioacetamide

Z. Hu, T. Kurihara, Y. Sun, Z. Cetin, R. M. Florentino, L. Faccioli, Z. Liu, B. Yang, A. Ostrowska, A. Soto-Gutierrez, E. Delgado

This study develops a rat model of cirrhosis-induced hepatocellular carcinoma using thioacetamide, showing fibrosis, altered liver architecture, and increased AFP levels.

bioRxiv · Apr 18, 2024Pathology

Human Induced Pluripotent Stem Cell based Hepatic-Modeling of Lipid metabolism associated TM6SF2 E167K variant

L. A. P. Faccioli, Y. Sun, T. Motomura, Z. Liu, T. Kurihara, Z. Hu, Z. Cetin, J. Franks, D. Stolz, A. Ostrowska, R. M. Florentino, I. J. Fox, A. Soto-Gutierrez

This study creates a human iPSC-derived hepatocyte model with the TM6SF2 E167K mutation to study its effects on lipid metabolism and MASLD.

bioRxiv · Dec 18, 2023Cell Biology

VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis

F. Rizvi, Y.-R. Lee, R. Diaz-Aragon, J. So, R. M. Florentino, A. R. Smith, E. Everton, A. Ostrowska, K. Jung, Y. Tam, H. Muramatsu, N. Pardi, D. Weissman, A. Soto-Gutierrez, D. Shin, V. Gouon-Evans

bioRxiv · Apr 17, 2023Pathology

Senescence-associated metabolomic phenotype in primary and iPSC-derived mesenchymal stromal cells

E. Fernandez-Rebollo, J. Franzen, J. Hollmann, A. Ostrowska, M. Oliverio, T. Sieben, B. Rath, J.-W. Kornfeld, W. Wagner

This study compares the metabolomic changes in primary and iPSC-derived mesenchymal stromal cells during replicative senescence, finding similar metabolic shifts in both cell types.

bioRxiv · Feb 6, 2019Cell Biology